![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.50 | 2.52% | 61.00 | 57.00 | 65.00 | 61.00 | 59.50 | 59.50 | 12,246 | 14:00:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 149k | -7.14M | -0.1082 | -5.64 | 39.26M |
RNS Number:0479S Celsis International PLC 5 October 2000 Announces Appointment of New Finance Director Celsis International plc is today pleased to announce the appointment of Mr Christian Madrolle as Finance Director. Mr Madrolle joins Celsis with more than 31 years international experience in finance and administration, most recently with the French Company Biocom, the main business of which is the supply of microbial monitoring instrumentation to the dairy sector world-wide. Mr Madrolle previously held a variety of positions with Xerox, Transport International and Portacabin. Mr Madrolle began his career at Xerox in 1969, where he became Finance and Administration Manager for the Paris region. He then joined Portacabin with the remit to establish a French subsidiary, firstly as General Manager, and then as Director in 1975. In 1981 Mr Madrolle joined Transport International (Amsterdam) as European Finance Director, and in 1982 was asked back by Portacabin to take up the position of General Manager for the European Division. Mr Madrolle became a main Board Director of Portacabin Ltd in 1985 with responsibility for the European operation. Dr Jack Rowell commented: "I am pleased to announce the appointment of Christian Madrolle who arrives at an important stage in the development of the Company. His many years of international experience in finance and administration, and his insight into the microbial testing and Dairy industry will be invaluable to us as we seek to expand and develop the business. I look forward to working with him as we take the business forward." Enquiries Celsis International plc Jack Rowell, Chief Executive +44-1223-426008 Brunswick Melissa Miller +44-207-404-5959 Notes to Editors Celsis International plc Celsis International plc specialises in the development and supply of rapid diagnostic and monitoring systems to detect and measure microbial contamination. It has successfully developed tests for use in the food, beverage, pharmaceutical, cosmetic and toiletries industries. These tests are based upon the technology of ATP Bioluminescence; such tests detect the presence of microbial contamination by monitoring light emitted when adenosine triphosphate ("ATP"), a naturally occurring substance present in all living organisms, is brought into contact with luciferase, an enzyme produced by fireflies.
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions